» Articles » PMID: 8536384

The Influence of Tetracyclines on T Cell Activation

Overview
Date 1995 Dec 1
PMID 8536384
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Minocycline has been shown to have an anti-inflammatory effect in patients with rheumatoid arthritis (RA). Since there is evidence that RA is a T cell-mediated disease, we investigated the effect of minocycline on human T cell clones derived from the synovium of an RA patient. The T cells, when activated via the T cell receptor (TCR)/CD3 complex, were suppressed functionally by minocycline, resulting in a dose-dependent inhibition of T cell proliferation and reduction in production of IL-2, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha). Besides an inhibition of IL-2 production, minocycline exerted its effect on T cell proliferation by induction of a decreased IL-2 responsiveness. We showed that the chelating capacity of minocycline plays a crucial role in the inhibitory effect on T cell function, since the inhibitory effect on T cell proliferation could be annulled by addition of exogenous Ca2+. However, minocycline did not markedly influence the typical TCR/CD3-induced intracellular Ca2+ mobilization. Taken together, the results clearly indicate that minocycline has immunomodulating effects on human T cells.

Citing Articles

Tetracyclines in Rheumatoid Arthritis: Dual Anti-Inflammatory and Immunomodulatory Roles, Effectiveness, and Safety Insights.

Radic M, Belancic A, dogas H, Vuckovic M, Gelemanovic A, Faour A Antibiotics (Basel). 2025; 14(1).

PMID: 39858351 PMC: 11762017. DOI: 10.3390/antibiotics14010065.


Tetracyclines enhance antitumor T-cell immunity via the Zap70 signaling pathway.

Tone M, Iwahori K, Hirata M, Ueyama A, Tani A, Haruta J J Immunother Cancer. 2024; 12(4).

PMID: 38621815 PMC: 11328671. DOI: 10.1136/jitc-2023-008334.


Host inflammatory response is the major factor in the progression of pneumonia.

Zhang Z, Wang P, Ma C, Wang J, Li W, Quan C Front Immunol. 2022; 13:929213.

PMID: 36119044 PMC: 9478202. DOI: 10.3389/fimmu.2022.929213.


Revisiting Minocycline in Intracerebral Hemorrhage: Mechanisms and Clinical Translation.

Zhang R, Yong V, Xue M Front Immunol. 2022; 13:844163.

PMID: 35401553 PMC: 8993500. DOI: 10.3389/fimmu.2022.844163.


Tetracyclines Diminish IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis.

Florou D, Mavropoulos A, Dardiotis E, Tsimourtou V, Siokas V, Aloizou A Front Immunol. 2021; 12:739186.

PMID: 34899697 PMC: 8662812. DOI: 10.3389/fimmu.2021.739186.


References
1.
Park J, Dow R . The uptake and localization of tetracycline in human blood cells. Br J Exp Pathol. 1970; 51(2):179-82. PMC: 2072235. View

2.
Kohn K . Mediation of divalent metal ions in the binding of tetracycline to macromolecules. Nature. 1961; 191:1156-8. DOI: 10.1038/1911156a0. View

3.
Martin R, Warr G, Couch R, Yeager H, Knight V . Effects of tetracycline on leukotaxis. J Infect Dis. 1974; 129(2):110-6. DOI: 10.1093/infdis/129.2.110. View

4.
Thong Y, Ferrante A . Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogues. Clin Exp Immunol. 1979; 35(3):443-6. PMC: 1537627. View

5.
Goodhart G . Further evidence for the role of bivalent cations in human polymorphonuclear leukocyte locomotion: recovery from tetracycline-induced inhibition in the presence of cation ionophores. J Reticuloendothel Soc. 1979; 25(5):545-54. View